13929-35-6,MFCD00135928
Catalog No.:AA001AMF

13929-35-6 | Rifamycin, 4-O-(carboxymethyl)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
1 week  
$209.00   $147.00
- +
25mg
1 week  
$317.00   $222.00
- +
100mg
1 week  
$602.00   $422.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA001AMF
Chemical Name:
Rifamycin, 4-O-(carboxymethyl)-
CAS Number:
13929-35-6
Molecular Formula:
C39H49NO14
Molecular Weight:
755.8047
MDL Number:
MFCD00135928
SMILES:
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(OCC(=O)O)cc(c(c2c(c3C)O)O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
Properties
Computed Properties
 
Complexity:
1460  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Defined Bond Stereocenter Count:
3  
Formal Charge:
0  
Heavy Atom Count:
54  
Hydrogen Bond Acceptor Count:
14  
Hydrogen Bond Donor Count:
6  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
4.8  

Literature

Title: Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B.

Journal: Acta biochimica et biophysica Sinica 20111201

Title: Role of extracellular protease in nitrogen substrate management during antibiotic fermentation: a process model and experimental validation.

Journal: Applied microbiology and biotechnology 20110801

Title: Development of balanced medium composition for improved rifamycin B production by isolated Amycolatopsis sp. RSP-3.

Journal: Letters in applied microbiology 20091101

Title: Expression of the bacterial hemoglobin gene from Vitreoscilla stercoraria increases rifamycin B production in Amycolatopsis mediterranei.

Journal: Journal of bioscience and bioengineering 20081101

Title: Detection of phase shifts in batch fermentation via statistical analysis of the online measurements: a case study with rifamycin B fermentation.

Journal: Journal of biotechnology 20071031

Title: Phase shifts in the stoichiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online.

Journal: Journal of biotechnology 20061215

Title: A cybernetic model to predict the effect of freely available nitrogen substrate on rifamycin B production in complex media.

Journal: Applied microbiology and biotechnology 20061001

Title: Structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation.

Journal: Biotechnology and bioengineering 20060305

Title: Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesis.

Journal: Journal of the American Chemical Society 20050817

Title: A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.

Journal: Chembiochem : a European journal of chemical biology 20050501

Title: Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei.

Journal: Journal of Zhejiang University. Science 20041201

Title: Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach.

Journal: Biotechnology and bioengineering 20040420

Title: Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.

Journal: Archives of biochemistry and biophysics 20030315

Title: Improvement of rifemycins production by Amycolatopsis mediterranei in batch and fed-batch cultures.

Journal: Acta microbiologica Polonica 20030101

Title: Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening.

Journal: The Journal of general and applied microbiology 20021201

Title: Solid state cultivation of Curvularia lunata for transformation of rifamycin B to S.

Journal: Indian journal of experimental biology 20020801

Title: New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways.

Journal: The Journal of antibiotics 20020401

Title: Antibiotic biosynthesis: from natural to unnatural compounds.

Journal: Journal of industrial microbiology & biotechnology 20010901

Title: The rifamycins.

Journal: Antibiotica et chemotherapia. Fortschritte. Advances. Progres 19630101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:13929-35-6 Molecular Formula|13929-35-6 MDL|13929-35-6 SMILES|13929-35-6 Rifamycin, 4-O-(carboxymethyl)-
Catalog No.: AA001AMF
13929-35-6,MFCD00135928
13929-35-6 | Rifamycin, 4-O-(carboxymethyl)-
Pack Size: 5mg
Purity:
1 week
$209.00 $147.00
Pack Size: 25mg
Purity:
1 week
$317.00 $222.00
Pack Size: 100mg
Purity:
1 week
$602.00 $422.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA001AMF
Chemical Name: Rifamycin, 4-O-(carboxymethyl)-
CAS Number: 13929-35-6
Molecular Formula: C39H49NO14
Molecular Weight: 755.8047
MDL Number: MFCD00135928
SMILES: CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c2c(OCC(=O)O)cc(c(c2c(c3C)O)O)NC(=O)/C(=C\C=C\[C@@H]([C@@H]([C@H]([C@H]([C@H]([C@@H]([C@@H]1C)OC(=O)C)C)O)C)O)C)/C
Properties
Complexity: 1460  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 9  
Defined Bond Stereocenter Count: 3  
Formal Charge: 0  
Heavy Atom Count: 54  
Hydrogen Bond Acceptor Count: 14  
Hydrogen Bond Donor Count: 6  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 4.8  
Literature fold

Title: Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B.

Journal: Acta biochimica et biophysica Sinica20111201

Title: Role of extracellular protease in nitrogen substrate management during antibiotic fermentation: a process model and experimental validation.

Journal: Applied microbiology and biotechnology20110801

Title: Development of balanced medium composition for improved rifamycin B production by isolated Amycolatopsis sp. RSP-3.

Journal: Letters in applied microbiology20091101

Title: Expression of the bacterial hemoglobin gene from Vitreoscilla stercoraria increases rifamycin B production in Amycolatopsis mediterranei.

Journal: Journal of bioscience and bioengineering20081101

Title: Detection of phase shifts in batch fermentation via statistical analysis of the online measurements: a case study with rifamycin B fermentation.

Journal: Journal of biotechnology20071031

Title: Phase shifts in the stoichiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online.

Journal: Journal of biotechnology20061215

Title: A cybernetic model to predict the effect of freely available nitrogen substrate on rifamycin B production in complex media.

Journal: Applied microbiology and biotechnology20061001

Title: Structured kinetic model to represent the utilization of multiple substrates in complex media during rifamycin B fermentation.

Journal: Biotechnology and bioengineering20060305

Title: Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesis.

Journal: Journal of the American Chemical Society20050817

Title: A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.

Journal: Chembiochem : a European journal of chemical biology20050501

Title: Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei.

Journal: Journal of Zhejiang University. Science20041201

Title: Optimization of rifamycin B fermentation in shake flasks via a machine-learning-based approach.

Journal: Biotechnology and bioengineering20040420

Title: Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.

Journal: Archives of biochemistry and biophysics20030315

Title: Improvement of rifemycins production by Amycolatopsis mediterranei in batch and fed-batch cultures.

Journal: Acta microbiologica Polonica20030101

Title: Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening.

Journal: The Journal of general and applied microbiology20021201

Title: Solid state cultivation of Curvularia lunata for transformation of rifamycin B to S.

Journal: Indian journal of experimental biology20020801

Title: New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways.

Journal: The Journal of antibiotics20020401

Title: Antibiotic biosynthesis: from natural to unnatural compounds.

Journal: Journal of industrial microbiology & biotechnology20010901

Title: The rifamycins.

Journal: Antibiotica et chemotherapia. Fortschritte. Advances. Progres19630101

Building Blocks More >
139502-80-0
139502-80-0
4'-Chlorobiphenyl-3-carbaldehyde
AA001B2I | MFCD03424622
13984-53-7
13984-53-7
Methyl 4-acetyl-5-oxohexanoate
AA001BO6 | MFCD00008760
1400744-17-3
1400744-17-3
(R)-(1-Tetrahydrofuran-3-yl)methanamine hydrochloride
AA001BXG | MFCD20526349
140447-78-5
140447-78-5
1((-2-N-Boc-amino)ethyl)piperazine
AA001CDF | MFCD02683050
1408002-86-7
1408002-86-7
(R)-2-(Hydroxymethyl)-1-methyl-4,4-difluoropyrrolidine
AA001CPT | MFCD23106101
14548-74-4
14548-74-4
1H,1H-2,5-Di(trifluoromethyl)-3,6-dioxaundecafluorononanol
AA001CZX | MFCD00339457
145781-92-6
145781-92-6
Goserelin Acetate
AA001DBP | MFCD01747329
146070-35-1
146070-35-1
2-Fluoro-3-(trifluoromethyl)benzonitrile
AA001DL4 | MFCD00061152
146368-07-2
146368-07-2
1-Ethyl-2,3,3-trimethyl-3H-indol-1-ium-5-sulfonate
AA001DVE | MFCD07369396
1467-35-2
1467-35-2
2,3,4-Trimethylaniline
AA001E6O | MFCD00130021
Submit
© 2017 AA BLOCKS, INC. All rights reserved.